(Q36381542)

13 August 2017

1 reference

title

Clinical implications of emerging pathogens in haemophilia: the variant Creutzfeldt-Jakob disease experience (English)

1 reference

Creutzfeldt-Jakob disease

13 August 2017

0 references

1 reference

1 reference

G Dolan

1

1 reference

13 August 2017

1 March 2006

1 reference

13 August 2017

1 reference

13 August 2017

12 Suppl 1

1 reference

13 August 2017

16-20; discussion 26-8

1 reference

GUIDELINES ON THERAPEUTIC PRODUCTS TO TREAT HAEMOPHILIA AND OTHER HEREDITARY COAGULATION DISORDERS.

13 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2006.01196.X

Human parvovirus B19 in young male patients with hemophilia A: associations with treatment product exposure and joint range-of-motion limitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2006.01196.X

New-variant Creutzfeldt-Jakob disease and treatment of haemophilia. Executive Committee of the UKHCDO. United Kingdom Haemophilia Centre Directors' Organisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2006.01196.X

Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2006.01196.X

Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2006.01196.X

10.1111/J.1365-2516.2006.01196.X

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference

PubMed ID

16445813